Priority Date: 05.08.08 (US 20080086355P)

Compositions and methods for antibodies targeting complement protein C5

  • Application ID: EP14175571
  • Status: The patent has been granted


Technology company logo small
Technology Company


no operation time available
1 office
Technology Company


This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 231 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.


  • 05.08.2008 - Priority Date (US 20080086355P)
  • 24.12.2014 - Publication A1 (EP2815766)
  • 05.07.2017 - Publication B1 (EP2815766)

IPC Classification